Showing 1,361 - 1,380 results of 1,670 for search '"artemisinin"', query time: 0.10s Refine Results
  1. 1361

    Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria by Rosauro Varo, Valerie M. Crowley, Antonio Sitoe, Lola Madrid, Lena Serghides, Rubao Bila, Helio Mucavele, Alfredo Mayor, Quique Bassat, Kevin C. Kain

    Published 2017-05-01
    “…The study was a prospective, randomized, double-blind, placebo-controlled, phase IIa trial of rosiglitazone (0.045 mg/kg/dose) twice daily for 4 days versus placebo as adjunctive treatment in addition to Mozambican standard of care (artemisinin combination therapy Coartem®) in children with uncomplicated malaria. …”
    Get full text
    Article
  2. 1362

    Investigating the Presence of Falsified and Poor-Quality Fixed-Dose Combination Artemether-Lumefantrine Pharmaceutical Dosage Forms in Kumasi, Ghana by Simon Nyarko, Kwabena Ofori-Kwakye, Raphael Johnson, Noble Kuntworbe, Denis Dekugmen Yar

    Published 2024-01-01
    “…Artemether-lumefantrine (AL) is a highly effective and commonly used Artemisinin-based Combination Therapy (ACT) for treating uncomplicated malaria caused by Plasmodium falciparum, including drug-resistant strains. …”
    Get full text
    Article
  3. 1363
  4. 1364
  5. 1365

    Planetary Health and Traditional Medicine: A Potential Synergistic Approach to Tackle Antimicrobial Resistance by Iyiola Olatunji Oladunjoye, Yusuf Amuda Tajudeen, Habeebullah Jayeola Oladipo, Mona Said El-Sherbini

    Published 2022-06-01
    “…Examples include the recent discovery of Artemisinin, a highly active antimalarial drug derived from <i>Artemisia annua</i>, and the discovery of Taxol, an active chemotherapeutic drug derived from the bark of the Pacific yew, <i>Taxus brevifolia</i>. …”
    Get full text
    Article
  6. 1366

    MYC2: A Master Switch for Plant Physiological Processes and Specialized Metabolite Synthesis by Lei Luo, Ying Wang, Lu Qiu, Xingpei Han, Yaqian Zhu, Lulu Liu, Mingwu Man, Fuguang Li, Maozhi Ren, Yadi Xing

    Published 2023-02-01
    “…Based on our understanding of the mechanism underlying the regulation of specialized metabolite synthesis in plants by the transcription factor MYC2, the use of synthetic biology approaches to design MYC2-driven chassis cells for the synthesis of specialized metabolites with high medicinal value, such as paclitaxel, vincristine, and artemisinin, seems to be a promising strategy. In this review, the regulatory role of MYC2 in JA signal transduction of plants to biotic and abiotic stresses, plant growth, development and specialized metabolite synthesis is described in detail, which will provide valuable reference for the use of MYC2 molecular switches to regulate plant specialized metabolite biosynthesis.…”
    Get full text
    Article
  7. 1367
  8. 1368

    Are rapid diagnostic tests more accurate in diagnosis of <it>plasmodium falciparum </it>malaria compared to microscopy at rural health centres? by Magnussen Pascal, Batwala Vincent, Nuwaha Fred

    Published 2010-12-01
    “…<p>Abstract</p> <p>Background</p> <p>Prompt, accurate diagnosis and treatment with artemisinin combination therapy remains vital to current malaria control. …”
    Get full text
    Article
  9. 1369

    Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria by Ya Tian, Zhongyuan Zheng, Xi Wang, Shuzhi Liu, Liwei Gu, Jing Mu, Xiaojun Zheng, Yujie Li, Shuo Shen

    Published 2022-07-01
    “…About 627,000 patients died of malaria in 2020. Currently, artemisinin and its derivatives are the front-line drugs used for the treatment of cerebral malaria. …”
    Get full text
    Article
  10. 1370

    Comparison of intermittent screening (using ultra-sensitive malaria rapid diagnostic test) and treatment (using a newly registered antimalarial pyronaridine-artesunate—PYRAMAX®) to... by Vivi Maketa, Japhet Kabalu, Melissa Kabena, Flory Luzolo, Hypolite Muhindo-Mavoko, Henk D. F. H. Schallig, Kassoum Kayentao, Petra F. Mens, Pascal Lutumba, Halidou Tinto

    Published 2022-11-01
    “…As an alternative, the intermittent screening and treatment for pregnancy (ISTp) aims at a monthly screening of pregnant women, preferably by using very sensitive tests such as ultrasensitive rapid diagnostic tests (us-RDTs) and the treatment of positive cases with artemisinin-based combination therapy (ACT) regardless of the presence of symptoms. …”
    Get full text
    Article
  11. 1371

    Dietary phytochemicals: As a potential natural source for treatment of Alzheimer's Disease by Zhuo Ren, Haixia Yang, Chenhui Zhu, Daidi Fan, Jianjun Deng

    Published 2023-01-01
    “…In this study, several representatives’ dietary phytochemicals with anti-AD effect, including resveratrol, lycopene, gallic acid, berberine, ginsenoside Rg1, pseudoginsenoside-F11, ginsenoside Rh2, artemisinin, and torularhodin were selected from the published data over the last 10 years and their potential molecular mechanisms and clinical applications reviewed in the treatment of AD.…”
    Get full text
    Article
  12. 1372

    Assessment of the performance and challenges in the implementation of the test, treat and track (T3) strategy for malaria control among children under-five years in Ghana by Margaret Kweku, Joyce B. Der, William K. Blankson, Haruna M. Salisu, Francis Arizie, Sorengmen A. Ziema, Jonathan M. Gmanyami, Fortress Y. Aku, Martin Adjuik

    Published 2022-01-01
    “…<h4>Background</h4> The World Health Organization recommended the Test, Treat and Track (T3) strategy for malaria control that, every suspected malaria case should be tested prior to treatment with Artemisinin-based combination therapy (ACT) and tracked. …”
    Get full text
    Article
  13. 1373

    Efficacy of antimalarial herbal medicines used by communities in malaria affected regions globally: a protocol for systematic review and evidence and gap map by Nakalembe Loyce, Robert Apunyo, Alison Annet Kinengyere, Moses Ocan, Ekwaro A Obuku, Kevin Ouma Ojiambo

    Published 2023-07-01
    “…Introduction With the rising resistance to artemisinin-based combination treatments, there is a need to hasten the discovery and development of newer antimalarial agents. …”
    Get full text
    Article
  14. 1374
  15. 1375
  16. 1376

    Impact of school-based malaria case management on school attendance, health and education outcomes: a cluster randomised trial in southern Malawi by Katherine E Halliday, Stefan S Witek-McManus, Austin Mtali, Andrew Bauleni, Saidi Ndau, Emmanuel Phondiwa, Doreen Ali, Virginia Kachigunda, John H Sande, Mpumulo Jawati, Allison Verney, Tiyese Chimuna, David Melody, Helen Moestue, Natalie Roschnik, Simon J Brooker, Don P Mathanga

    Published 2020-01-01
    “…The intervention, implemented in 29 randomly selected schools, provided malaria rapid diagnostic tests and artemisinin-based combination therapy to diagnose and treat uncomplicated malaria as part of basic first aid kits known as ‘Learner Treatment Kits’ (LTK). …”
    Get full text
    Article
  17. 1377

    Anti-malarial market and policy surveys in sub-Saharan Africa by Sevcsik Ann-Marie, Boakye Isaac, Amuasi John, Diap Graciela, Pecoul Bernard

    Published 2010-04-01
    “…<p>Abstract</p> <p>At a recent meeting (Sept 18, 2009) in which reasons for the limited access to artemisinin-based combination therapy (ACT) in sub-Saharan Africa were discussed, policy and market surveys on anti-malarial drug availability and accessibility in Burundi and Sierra Leone were presented in a highly interactive brainstorming session among key stakeholders across private, public, and not-for-profit sectors. …”
    Get full text
    Article
  18. 1378
  19. 1379

    Molecular markers of dihydroartemisinin-piperaquine resistance in northwestern Thailand by Khine Nwe Win, Khajohnpong Manopwisedjaroen, Kanit Phumchuea, Chayanut Suansomjit, Kesinee Chotivanich, Saranath Lawpoolsri, Liwang Cui, Jetsumon Sattabongkot, Wang Nguitragool

    Published 2022-11-01
    “…Results Among the samples whose kelch13 were successfully sequenced, approximately half (31/55; 56%) had mutation associated with artemisinin resistance, including G533S (23/55; 42%), C580Y (6/55; 11%), and G538V (2/55; 4%). …”
    Get full text
    Article
  20. 1380

    The evolution of pyrimethamine resistant <it>dhfr </it>in <it>Plasmodium falciparum </it>of south-eastern Tanzania: comparing selection under SP alone <it>vs </it>SP+artesunate com... by Mshinda Hassan, Kachur Patrick S, Abdullah Salim, Mutayoba Ben M, Pearce Richard J, Malisa Allen L, Bloland Peter, Roper Cally

    Published 2011-10-01
    “…<p>Abstract</p> <p>Background</p> <p>Sulphadoxine-pyrimethamine (SP) resistance is now widespread throughout east and southern Africa and artemisinin compounds in combination with synthetic drugs (ACT) are recommended as replacement treatments by the World Health Organization (WHO). …”
    Get full text
    Article